home All News open_in_new Full Article

Alkem Labs Q2 Review: Dolat Capital Upgrades EPS Estimate For FY26

Dolat Capital upgrades Alkem Labs' FY26E/FY27E EPS estimates by 3.5%/6.0%, assuming higher sales and Ebitda margin.


today 1 week ago attach_file Politics

attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Economics


ID: 1679525801
Add Watch Country

arrow_drop_down